poly(ethylene glycol)-poly(caprolactone)-poly(ethylene glycol)

Also Known As:

PEG-PCL-PEG; PEO-PCL-PEO

Networked: 10 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Macromolecular Substances: 97
- Polymers: 13051
  - Polyethylene Glycols: 3865
    - poly(ethylene glycol)-poly(caprolactone)-poly(ethylene glycol): 10
  - Polyesters: 921
    - poly(ethylene glycol)-poly(caprolactone)-poly(ethylene glycol): 10
Biomedical and Dental Materials
- Polymers: 13051
  - Polyethylene Glycols: 3865
    - poly(ethylene glycol)-poly(caprolactone)-poly(ethylene glycol): 10
  - Polyesters: 921
    - poly(ethylene glycol)-poly(caprolactone)-poly(ethylene glycol): 10
Technology, Industry, and Agriculture
- Manufactured Materials
  - Biomedical and Dental Materials
    - Polymers: 13051
      - Polyethylene Glycols: 3865
        poly(ethylene glycol)-poly(caprolactone)-poly(ethylene glycol): 10
      - Polyesters: 921
        poly(ethylene glycol)-poly(caprolactone)-poly(ethylene glycol): 10
Organic Chemicals: 133
- Alcohols: 595
  - Glycols: 38
    - Ethylene Glycols: 8
      - Polyethylene Glycols: 3865
        poly(ethylene glycol)-poly(caprolactone)-poly(ethylene glycol): 10

Experts

1.	Zhang, Yu: 2 articles (01/2018 - 12/2009)
2.	Li, Xiabin: 2 articles (08/2015 - 01/2014)
3.	Peng, Ribo: 2 articles (08/2015 - 01/2014)
4.	Qian, Zhiyong: 2 articles (08/2015 - 01/2014)
5.	Yu, Ling: 2 articles (08/2015 - 01/2014)
6.	Gong, ChangYang: 2 articles (09/2010 - 12/2009)
7.	Luo, Feng: 2 articles (09/2010 - 12/2009)
8.	Qian, ZhiYong: 2 articles (09/2010 - 12/2009)
9.	Wei, YuQuan: 2 articles (09/2010 - 12/2009)
10.	Zhao, Xia: 2 articles (09/2010 - 12/2009)

Related Diseases

1.	Malignant Pleural Effusion 12/22/2009 - "And we wonder whether a novel honokiol nanoparticles-loaded thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) (PEG-PCL-PEG, PECE) hydrogel (HK-hydrogel) could improve the therapeutic efficacy on malignant pleural effusion (MPE). "
2.	Neoplasms (Cancer) 06/01/2022 - "Cancer stem cells (CSCs) inhibitor Salinomycin (SAL) and non-CSC inhibitor Docetaxel (DOC) were co-loaded in the NPs and delivered by liquid PEG-PCL-PEG gel (PECE) at room temperature, which was able to target tumor and formed a gel in situ at body temperature. " 01/02/2018 - "We aimed to explore the anti-tumor effect and mechanism of the combination of cisplatin (DDP)-containing thermosensitive hydrogel (PEG-PCL-PEG, or PECE) and paclitaxel (PTX)-loaded MPEG-PCL polymeric micelles called PDMP on human cervical carcinoma (HeLa) cell. "
3.	Glaucoma 01/01/2014 - "The PEG-PCL-PEG Hydrogel as an Implanted Ophthalmic Delivery System after Glaucoma Filtration Surgery; a Pilot Study." 08/01/2015 - "Effects of bevacizumab loaded PEG-PCL-PEG hydrogel intracameral application on intraocular pressure after glaucoma filtration surgery."
4.	Wounds and Injuries (Trauma) 02/15/2020 - "The SPU with PEG-PCL-PEG soft segments is an excellent candidate for wound dressing in tissues undergoing large deformations during normal activities."
5.	Lung Neoplasms (Lung Cancer) 12/01/2021 - "As an outcome, we have developed biodegradable triblock poly(ethylene glycol)-poly(ε-caprolactone)-poly(ethylene glycol) (PEG-PCL-PEG, PECE) polymeric NPs for the co-delivery of sorafenib (SORA) and crizotinib (CRIZ) and investigated their effect on lung cancer by in vitro and in vivo. "

Related Drugs and Biologics

1.	Hydrogels
2.	Ethylene Glycol (Monoethylene Glycol)
3.	polycaprolactone
4.	honokiol
5.	Micelles
6.	caprolactone
7.	Paclitaxel (Taxol)
8.	Vancomycin
9.	Doxorubicin (Adriamycin)
10.	Cisplatin (Platino)

Related Therapies and Procedures

1.	Filtering Surgery